PATENT CLAIM ANALYSIS

Application Number: 15891324
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "027000"]

Abstract:
Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.

Claim (Index 64):
The method of  claim 48 , further comprises administering resveratrol.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 88.0
- Lexical Diversity: 1.45833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14442711', '14843873', '15119695', '14746516', '15817057']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8242087569693098
- 35 USC 102 Novelty (BERT): 0.6102312918022886
- Combined Prediction Score: 0.8028110104526077
- Mean Citation Score: 533.259804
- Max Citation Score: 719.5933
- Similarity Product: 459.6831663786412

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test